Skip to main content
. 2020 Jun 23;8:238. doi: 10.3389/fped.2020.00238

Table 1.

Comparisons between different treatment groups for direct and indirect outcome measures.

Treatment comparison Moderate or severe neuro-disability, or death Moderate or severe neuro-disability VP shunt or death VP shunt Death
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Compared to Control
CSF removal 1.01 (0.86–1.19) 0.921 0.87 (0.45–1.70) 0.689 0.96 (0.8–1.15) 0.652 0.97 (0.75–1.24) 0.791 0.91 (0.53–1.57) 0.739
Diuretics 1.17 (0.99–1.39) 0.062 1.05 (0.47–2.34) 0.905 1.20 (0.93–1.54) 0.165 1.07 (0.79–1.44) 0.676 1.58 (0.81–3.08) 0.179
DRIFT 0.80 (0.53–1.22) 0.302 0.87 (0.35–2.17) 0.759 0.97 (0.62–1.53) 0.91 1.04 (0.6–1.79) 0.89 0.58 (0.15–2.28) 0.439
Early CSF removal 0.80 (0.47–1.37) 0.421 0.80 (0.39–1.67) 0.556 0.77 (0.26–2.32) 0.645
Fibrinolytics 1.20 (0.52–2.77) 0.675 1.41 (0.70–2.84) 0.342 1.26 (0.20–7.76) 0.806
Compared to CSF Removal
Diuretics 1.16 (0.92–1.47) 0.20 1.20 (0.42–3.42) 0.73 1.25 (0.91–1.70) 0.16 1.1 (0.75–1.63) 0.62 1.73 (0.73–4.10) 0.21
DRIFT 0.80 (0.51–1.24) 0.32 0.99 (0.32–3.09) 0.99 1.02 (0.62–1.65) 0.95 1.07 (0.59–1.96) 0.81 0.64 (0.15–2.78) 0.55
Early CSF removal 0.84 (0.51–1.39) 0.49 0.83 (0.42–1.65) 0.60 0.85 (0.33–2.20) 0.73
Fibrinolytics 1.25 (0.53–2.94) 0.61 1.45 (0.69–3.07) 0.33 1.38 (0.21–9.22) 0.74
Compared to Diuretic
DRIFT 0.69 (0.44–1.07) 0.10 0.82 (0.24–2.79) 0.76 0.81 (0.48–1.37) 0.44 0.97 (0.52–1.82) 0.94 0.37 (0.08–1.68) 0.20
Early CSF removal 1.49 (0.37–1.21) 0.19 0.75 (0.34–1.66) 0.48 0.49 (0.14–1.77) 0.28
Fibrinolytics 1.00 (0.45–2.23) 1.00 1.32 (0.64–2.71) 0.45 0.80 (0.13–4.91) 0.81
Compared to DRIFT
Early CSF removal 0.82 (0.41–1.66) 0.59 0.77 (0.31–1.92) 0.58 1.32 (0.23–7.59) 0.76
Fibrinolytics 1.23 (0.47–3.19) 0.67 1.35 (0.56–3.29) 0.51 2.15 (0.22–20.84) 0.51
Compared to Early CSF Removal
Fibrinolytics 1.49 (0.55–4.04) 0.43 1.75 (0.63–4.83) 0.28 1.63 (0.19–13.62) 0.65